MLXIPL and metabolic dysfunction-associated steatotic liver disease: Moreover, the NAFLD model demonstrated that AMPKα is a negative regulator of sterol element-binding protein 1-c (SREBP 1-c) and carbohydrate response element-binding protein (ChREBP).